| |
 |
|
Class Information
Number: 514/907
Name: Drug, bio-affecting and body treating compositions > Muscular dystrophy
Description: Subject matter involving the treatment, prevention or alleviation of symptoms of muscular dystrophy.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 8426355 |
Methods of treating muscular wasting diseases using NF-.kappa.B activation inhibitors |
Apr. 23, 2013 |
| 8334279 |
Non-hormonal steroid modulators of NF-.kappa.B for treatment of disease |
Dec. 18, 2012 |
| 8247460 |
Method of treatment for muscular dystrophy |
Aug. 21, 2012 |
| 7232580 |
Use of extracts of Ginkgo biloba for preparing a medicament intended to treat sarcopenia |
Jun. 19, 2007 |
| 7138148 |
Use of extracts of Ginkgo biloba for preparing a medicament intended to treat sarcopenia |
Nov. 21, 2006 |
| 6596709 |
6-sulphanoyl-3-quinolylphosphonic acid compounds |
Jul. 22, 2003 |
| 6413968 |
Treatment of myasthenia gravis by cyclic nucleotide phosphodiesterase inhibition |
Jul. 2, 2002 |
| 6261560 |
Method for inhibiting muscle protein proteolysis with antibodies to interleukin-6 receptor |
Jul. 17, 2001 |
| 6060480 |
Preventives/remedies for muscle tissue degenerations |
May. 9, 2000 |
| 5981536 |
Use of xanthine derivatives for the modulation of apoptosis |
Nov. 9, 1999 |
| 5912005 |
Methods of use of uncoated gel particles |
Jun. 15, 1999 |
| 5856330 |
Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin |
Jan. 5, 1999 |
| 5651980 |
Methods of use of uncoated gel particles |
Jul. 29, 1997 |
| 5552442 |
Therapeutic applications of clenbuterol |
Sep. 3, 1996 |
| 5541188 |
Therapeutic applications of beta-adrenergic agonists |
Jul. 30, 1996 |
| 5541074 |
Antibodies to dystrophin and uses therefor |
Jul. 30, 1996 |
| 5530029 |
Therapeutic applications of clenbuterol |
Jun. 25, 1996 |
| 5434142 |
Method of treatment for muscular dystrophy |
Jul. 18, 1995 |
| 5130141 |
Compositions for and methods of treating muscle degeneration and weakness |
Jul. 14, 1992 |
| 5070079 |
Pharmaceutical compositions containing cytidine monophosphate of 5-acetamido-3-, 5-D-deoxy-D-glycero-D-galacto-nonulosamic acid |
Dec. 3, 1991 |
| 4885167 |
Restoration of impaired cardiac function of patients with diverse muscular dystrophies by therapy with coenzyme Q10 |
Dec. 5, 1989 |
| 4741902 |
Compositions for treatment of neurological and related disorders |
May. 3, 1988 |
| 4684520 |
Pharmaceutical compositions having cerebral antianoxic and metabolic activities |
Aug. 4, 1987 |
| 4677121 |
Method of inhibiting muscle protein degradation |
Jun. 30, 1987 |
| 4418075 |
Epoxysuccinyl amino acid derivatives |
Nov. 29, 1983 |
| 4416885 |
Use of isopropylaminopyrimidine in the chemotherapy of muscular dystrophy, myopathy and myotonia |
Nov. 22, 1983 |
| 4344947 |
Use of isopropylaminopyrimidine in the chemotherapy of muscular dystrophy, myopathy and mytonia |
Aug. 17, 1982 |
| 4145421 |
Treating spastic conditions |
Mar. 20, 1979 |
| 3956374 |
Aryl-oxo-heptenoic acids |
May. 11, 1976 |
|
|
|
